NIAID Clinical Research Support Services 2017-2024

The National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) established this Master IDIQ on July 31, 2017 to provide general clinical research support services for the Vaccine Research Center's vaccine, therapeutic, and diagnostic development efforts, including clinical trial coordination, site monitoring, regulatory support, and compliance services. Ordering closed on July 31, 2024; the vehicle is no longer active and no new orders may be placed against it.

The vehicle obligated $2.2 million of its $2.3 million combined potential value across 15 task orders, with no successor vehicle mentioned in the source. Ordering momentum declined sharply in the final years: the vehicle sustained three orders per year from 2019 through 2021, dropped to one order in 2022, and issued one final order in July 2023. The most recent task order completion was scheduled for January 2026, indicating remaining performance activities extend into this year.

Work contracted consists of clinical trial support for infectious disease and vaccine programs, including site implementation and oversight for malaria trials, regulatory support for HIV monoclonal antibody and influenza vaccine development, COVID-19 clinical research, and Ebola monoclonal antibody trials. All orders use cost-plus-fixed-fee pricing.

The Emmes Company, LLC dominated the vehicle by potential value with $1.4 million across four orders, while Technical Resources International, Inc. led by order count with ten orders totaling $843 thousand in potential value. Social & Scientific Systems, Inc. received one order for $5 thousand. All customer funding came from NIAID alone.

Eighty percent of orders carried no set-aside designation, with the remaining 20 percent (three orders) designated for total small business. Individual task-order values ranged from $5 thousand to approximately $1.1 million, with typical orders in the $50 thousand range. The largest single order was a malaria clinical trial support contract for $1.1 million, awarded in July 2021.

The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Vaccine Research Center (VRC) has a requirement for General Clinical Research Support Services. The Contractor will coordinate clinical activities and complete all necessary clinical trial activities to support the VRC's clinical research efforts and enable the VRC to rapidly establish collaborations with academic institutions and health research organizations in response to the urgent research demands of global importance. The contractor will also be tasked in providing comprehensive clinical site and study monitoring services for the VRC's clinical research efforts as well as regulatory support and compliance services.